Vulnerability · Published Jan 20, 2026 · Assigned by oracle

CVE-2026-21974

Medium 5.3

In plain English

A medium-severity information exposure in Oracle Life Sciences Central Designer from Oracle Corporation. There are no confirmed reports of exploitation so far. The chance it is exploited in the next 30 days is estimated at 0.3% (higher than 17% of all known vulnerabilities).

Severity (CVSS 3.1)5.3Medium

Exploit odds (30 days)0.3%top 82.8% of all CVEs

Exploited in the wildNo reportsCISA SSVC: none

Attack toolingNoneno public tooling known

Official description

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).

Affected products (as reported)

Vendor	Product	Versions
Oracle Corporation	Oracle Life Sciences Central Designer	7.0.1.0

Weakness: CWE-200 · Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

References

Oracle Advisory vendor-advisory